Works by Elliott, Michelle A.

Results: 80
    1

    Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00891-x
    By:
    • Abdelmagid, Maymona G.;
    • Al-Kali, Aref;
    • Litzow, Mark R.;
    • Begna, Kebede H.;
    • Hogan, William J.;
    • Patnaik, Mirinal S.;
    • Hashmi, Shahrukh K.;
    • Elliott, Michelle A.;
    • Alkhateeb, Hassan;
    • Karrar, Omer S.;
    • Fleti, Farah;
    • Elnayir, Mohammed H.;
    • Rivera, Candido E.;
    • Murthy, Hemant S.;
    • Foran, James M.;
    • Kharfan-Dabaja, Mohamed A.;
    • Badar, Talha;
    • Viswanatha, David S.;
    • Reichard, Kaaren K.;
    • Gangat, Naseema
    Publication type:
    Article
    2

    Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00812-y
    By:
    • Abdallah, Mostafa;
    • McCullough, Kristen;
    • Ilyas, Rimal;
    • Begna, Kebede H.;
    • Al-Kali, Aref;
    • Litzow, Mark R.;
    • Hogan, William J.;
    • Mangaonkar, Abhishek;
    • Alkhateeb, Hassan;
    • Shah, Mithun V.;
    • Elliott, Michelle A.;
    • Foran, James M.;
    • Badar, Talha;
    • Palmer, Jeanne M.;
    • Yi, Cecilia Arana;
    • Sproat, Lisa;
    • Pardanani, Animesh;
    • Patnaik, Mrinal M.;
    • Olteanu, Horatiu;
    • Ketterling, Rhett P.
    Publication type:
    Article
    3

    Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

    Published in:
    2023
    By:
    • Abdallah, Mostafa;
    • McCullough, Kristen;
    • Ilyas, Rimal;
    • Begna, Kebede H.;
    • Al-Kali, Aref;
    • Litzow, Mark R.;
    • Hogan, William J.;
    • Mangaonkar, Abhishek;
    • Alkhateeb, Hassan;
    • Shah, Mithun V.;
    • Elliott, Michelle A.;
    • Foran, James M.;
    • Badar, Talha;
    • Palmer, Jeanne M.;
    • Yi, Cecilia Arana;
    • Sproat, Lisa;
    • Pardanani, Animesh;
    • Patnaik, Mrinal M.;
    • Olteanu, Horatiu;
    • Ketterling, Rhett P.
    Publication type:
    Letter
    4

    Mayo Clinic experience with 1123 adults with acute myeloid leukemia.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00435-1
    By:
    • Begna, Kebede H.;
    • Ali, Walid;
    • Naseema Gangat;
    • Elliott, Michelle A.;
    • Al-Kali, Aref;
    • Litzow, Mark R.;
    • Christopher Hook, C.;
    • Wolanskyj-Spinner, Alexandra P.;
    • Hogan, William J.;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Zblewski, Darci L.;
    • Chen, Dong;
    • He, Rong;
    • Viswanatha, David;
    • Hanson, Curtis A.;
    • Ketterling, Rhett P.;
    • Tefferi, Ayalew
    Publication type:
    Article
    5

    A population-based study of chronic neutrophilic leukemia in the United States.

    Published in:
    2020
    By:
    • Ruan, Gordon J.;
    • Smith, Caleb J.;
    • Day, Courtney;
    • Harmsen, William S.;
    • Zblewski, Darci L.;
    • Alkhateeb, Hassan;
    • Begna, Kebede;
    • Al-Kali, Aref;
    • Litzow, Mark R.;
    • Hogan, William;
    • Szuber, Natasha;
    • Gangat, Naseema;
    • Patnaik, Mrinal S.;
    • Pardanani, Animesh;
    • Elliott, Michelle A.;
    • Tefferi, Ayalew;
    • Go, Ronald S.;
    • Shah, Mithun V.
    Publication type:
    Letter
    6

    Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1592, doi. 10.1080/10428194.2020.1737684
    By:
    • Bubik, Rachel J.;
    • Barth, Dylan M.;
    • Hook, Christopher;
    • Wolf, Robert C.;
    • Muth, Jessica M.;
    • Mara, Kristin;
    • Patnaik, Mrinal S.;
    • Pruthi, Rajiv K.;
    • Marshall, Ariela L.;
    • Litzow, Mark R.;
    • Elliott, Michelle A.;
    • Hogan, William J.;
    • Shah, Mithun V.;
    • Begna, Kebede H.;
    • Alkhateeb, Hassan;
    • Pardanani, Animesh;
    • Ashrani, Aneel A.;
    • Call, Timothy G.;
    • Rivera, Candido E.;
    • Camoriano, John K.
    Publication type:
    Article
    7
    8

    Elderly acute lymphoblastic leukemia: a Mayo Clinic study of 124 patients.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 4, p. 990, doi. 10.1080/10428194.2018.1509318
    By:
    • Miller, Kevin C.;
    • Al-Kali, Aref;
    • Shah, Mithun V.;
    • Hogan, William J.;
    • Elliott, Michelle A.;
    • Begna, Kebede H.;
    • Gangat, Naseema;
    • Patnaik, Mrinal M.;
    • Viswanatha, David S.;
    • He, Rong;
    • Greipp, Patricia T.;
    • Sproat, Lisa Z.;
    • Foran, James M.;
    • Litzow, Mark R.;
    • Alkhateeb, Hassan B.
    Publication type:
    Article
    9
    10
    11

    Safety and feasibility of lower antithrombin replacement targets in adult patients with hematological malignancies receiving asparaginase therapy.

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 11, p. 2588, doi. 10.1080/10428194.2017.1312384
    By:
    • Barreto, Jason N.;
    • McCullough, Kristen B.;
    • Peskey, Candy S.;
    • Dierkhising, Ross A.;
    • Mara, Kristin C.;
    • Elliott, Michelle A.;
    • Gastineau, Dennis A.;
    • Al-Kali, Aref;
    • Gangat, Naseema;
    • Letendre, Louis;
    • Hogan, William J.;
    • Litzow, Mark R.;
    • Patnaik, Mrinal M.
    Publication type:
    Article
    12
    13

    A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin.

    Published in:
    Leukemia & Lymphoma, 2013, v. 54, n. 8, p. 1713, doi. 10.3109/10428194.2012.753444
    By:
    • Larsen, Jeremy T.;
    • Hogan, William J.;
    • Micallef, Ivana N.;
    • Dispenzieri, Angela;
    • Gertz, Morie A.;
    • Inwards, David J.;
    • Tun, Han W.;
    • Roy, Vivek;
    • Geyer, Susan M.;
    • Allred, Jacob B.;
    • Wu, Wenting;
    • Ansell, Stephen M.;
    • Elliott, Michelle A.;
    • Tefferi, Ayalew;
    • Porrata, Luis F.;
    • Gastineau, Dennis A.;
    • Lacy, Martha Q.;
    • Litzow, Mark R.
    Publication type:
    Article
    14

    Comparison of complication rates of Hickman<sup>®</sup> catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy.

    Published in:
    Leukemia & Lymphoma, 2013, v. 54, n. 6, p. 1263, doi. 10.3109/10428194.2012.742520
    By:
    • Lim, Ming Y.;
    • Al-Kali, Aref;
    • Ashrani, Aneel A.;
    • Begna, Kebede H.;
    • Elliott, Michelle A.;
    • Hogan, William J.;
    • Hook, C. Christopher;
    • Kaufmann, Scott H.;
    • Letendre, Louis;
    • Litzow, Mark R.;
    • Patnaik, Mrinal S.;
    • Pardanani, Animesh;
    • Tefferi, Ayalew;
    • Wolanskyj, Alexandra P.;
    • Grill, Diane E.;
    • Pruthi, Rajiv K.
    Publication type:
    Article
    15

    Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 2, p. 260, doi. 10.1002/ajh.27564
    By:
    • Gangat, Naseema;
    • Elbeih, Azeem;
    • Ghosoun, Nour;
    • McCullough, Kristen;
    • Aperna, Fnu;
    • Johnson, Isla M.;
    • Abdelmagid, Maymona;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan B.;
    • Begna, Kebede H.;
    • Elliott, Michelle;
    • Mangaonkar, Abhishek;
    • Matin, Aasiya;
    • Saliba, Antoine N.;
    • Hefazi Torghabeh, Mehrdad;
    • Litzow, Mark R.;
    • Hogan, William;
    • Shah, Mithun;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh
    Publication type:
    Article
    16
    17

    Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 2, p. E63, doi. 10.1002/ajh.27180
    By:
    • Karrar, Omer;
    • Abdelmagid, Maymona;
    • Rana, Masooma;
    • Iftikhar, Moazah;
    • McCullough, Kristen;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan B.;
    • Begna, Kebede H.;
    • Elliott, Michelle A.;
    • Mangaonkar, Abhishek;
    • Saliba, Antoine;
    • Hefazi Torghabeh, Mehrdad;
    • Litzow, Mark R.;
    • Hogan, William;
    • Shah, Mithun;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Badar, Talha;
    • Murthy, Hemant;
    • Foran, James
    Publication type:
    Article
    18

    Mast cell cytomorphology and treatment outcome in mast cell leukemia.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 1, p. E5, doi. 10.1002/ajh.27105
    By:
    • Tefferi, Ayalew;
    • Pardanani, Animesh;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan;
    • McCullough, Kristen;
    • Patnaik, Mrinal;
    • Hogan, William J.;
    • Begna, Kebede;
    • Elliott, Michelle A.;
    • Khera, Nandita;
    • Palmer, Jeanne M.;
    • Gangat, Naseema;
    • Kelemen, Katalin;
    • Orazi, Attilio;
    • Chen, Dong;
    • Reichard, Kaaren K.
    Publication type:
    Article
    19
    20

    Bortezomib and daratumumab in refractory autoimmune hemolytic anemia.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 10, p. E263, doi. 10.1002/ajh.27025
    By:
    • McGlothlin, John;
    • Abeykoon, Jithma;
    • Al‐Hattab, Eyad;
    • Ashrani, Aneel A.;
    • Elliott, Michelle;
    • Hook, C. Christopher;
    • Pardanani, Animesh;
    • Pruthi, Rajiv;
    • Sridharan, Meera;
    • Wolanskyj, Alexandra;
    • Rouse, Rachelle;
    • Go, Ronald
    Publication type:
    Article
    21

    TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo‐Moffitt study of 156 informative cases.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 4, p. E76, doi. 10.1002/ajh.26845
    By:
    • Fleti, Farah;
    • Chan, Onyee;
    • Singh, Amritpal;
    • Abdelmagid, Maymona G.;
    • Al‐Kali, Aref;
    • Elliott, Michelle A.;
    • Begna, Kebede H.;
    • Foran, James M.;
    • Badar, Talha;
    • Khera, Nandita;
    • Al Ali, Najla H.;
    • Padron, Eric;
    • Sallman, David A.;
    • Shah, Mithun;
    • Hiwase, Devendra;
    • Pardanani, Animesh;
    • Arber, Daniel A.;
    • Orazi, Attilio;
    • Reichard, Kaaren K.;
    • He, Rong
    Publication type:
    Article
    22

    Lenalidomide therapy for primary myelodysplastic syndromes with isolated del(5q): Determinants of response and survival in a real‐world setting.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 10, p. E377, doi. 10.1002/ajh.26672
    By:
    • Singh, Amritpal;
    • Al‐Kali, Aref;
    • Foran, James M.;
    • Elliott, Michelle A.;
    • Begna, Kebede;
    • Badar, Talha;
    • Khera, Nandita;
    • Fleti, Farah;
    • Abdelmagid, Maymona;
    • Reichard, Kareen K.;
    • Ketterling, Rhett P.;
    • Pardanani, Animesh;
    • Gangat, Naseema;
    • Tefferi, Ayalew
    Publication type:
    Article
    23

    A dynamic 3‐factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 9, p. 1127, doi. 10.1002/ajh.26630
    By:
    • Tefferi, Ayalew;
    • Gangat, Naseema;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan;
    • Shah, Mithun;
    • Patnaik, Mrinal S.;
    • Elliott, Michelle A.;
    • Hogan, William J.;
    • Litzow, Mark R.;
    • Hook, Christopher C.;
    • Mangaonkar, Abhishek;
    • Viswanatha, David;
    • Chen, Dong;
    • Pardanani, Animesh;
    • Ketterling, Rhett P.;
    • DiNardo, Courtney D.;
    • Kadia, Tapan M.;
    • Ravandi, Farhad;
    • Sasaki, Koji;
    • Begna, Kebede H.
    Publication type:
    Article
    24
    25
    26

    Venetoclax with azacitidine or decitabine in blast‐phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 7, p. 781, doi. 10.1002/ajh.26186
    By:
    • Gangat, Naseema;
    • Guglielmelli, Paola;
    • Szuber, Natasha;
    • Begna, Kebede H.;
    • Patnaik, Mrinal M.;
    • Litzow, Mark R.;
    • Al‐Kali, Aref;
    • Foran, James M.;
    • Palmer, Jeanne M.;
    • Alkhateeb, Hassan;
    • Elliott, Michelle A.;
    • Hanson, Curtis A.;
    • Pardanani, Animesh;
    • Mannelli, Francesco;
    • Vannucchi, Alessandro M.;
    • Tefferi, Ayalew
    Publication type:
    Article
    27

    Acute myeloid leukemia after age 70 years: A retrospective comparison of survival following treatment with intensive versus HMA ± venetoclax chemotherapy.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 4, p. E108, doi. 10.1002/ajh.26112
    By:
    • Begna, Kebede H.;
    • Gangat, Naseema;
    • Al‐Kali, Aref;
    • Litzow, Mark R.;
    • Hogan, William J.;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Hook, C. Christopher;
    • Wolanskyj, Alexandra P.;
    • Elliott, Michelle A.;
    • Hanson, Curtis A.;
    • Ketterling, Rhett P.;
    • Tefferi, Ayalew
    Publication type:
    Article
    28
    29

    Clinical utility of fluorescence in situ hybridization‐based diagnosis of BCR‐ABL1 like (Philadelphia chromosome like) B‐acute lymphoblastic leukemia.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 3, p. E68, doi. 10.1002/ajh.25729
    By:
    • Anagnostou, Theodora;
    • Knudson, Ryan A.;
    • Pearce, Kathryn E.;
    • Meyer, Reid G.;
    • Pitel, Beth A.;
    • Peterson, Jess F.;
    • Baughn, Linda B.;
    • Reichard, Kaaren K.;
    • Ketterling, Rhett P.;
    • Kloft‐Nelson, Sara M.;
    • Knutson, Darlene L.;
    • Khan, Shakila P.;
    • Gangat, Naseema;
    • Litzow, Mark R.;
    • Hogan, William J.;
    • Wolanskyj, Alexandra;
    • Al‐Kali, Aref;
    • Begna, Kebede H.;
    • Elliott, Michelle;
    • Pardanani, Animesh
    Publication type:
    Article
    30
    31
    32

    A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3‐ITD mutational status.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 12, p. E401, doi. 10.1002/ajh.25290
    By:
    • Begna, Kebede H.;
    • Ali, Walid;
    • Gangat, Naseema;
    • Elliott, Michelle A.;
    • Al‐Kali, Aref;
    • Litzow, Mark R.;
    • Hook, C. Christopher;
    • Wolanskyj, Alexandra P.;
    • Hogan, William J.;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Zblewski, Darci L.;
    • Chen, Dong;
    • He, Rong;
    • Viswanatha, David;
    • Hanson, Curtis A.;
    • Ketterling, Rhett P.;
    • Tefferi, Ayalew
    Publication type:
    Article
    33

    Pre‐anthracycline echocardiogram rarely changes treatment strategy in acute myeloid leukemia.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 6, p. E144, doi. 10.1002/ajh.25083
    By:
    • Ogden, John;
    • Yui, Jennifer;
    • Ali, Walid;
    • Mudireddy, Mythri;
    • Al‐Kali, Aref;
    • Patnaik, Mrinal;
    • Gangat, Naseema;
    • Elliott, Michelle;
    • Hogan, William;
    • Hook, Christopher;
    • Wolanskyj‐Spinner, Alexandra;
    • Pardanani, Animesh;
    • Villarraga, Hector;
    • Litzow, Mark;
    • Tefferi, Ayalew;
    • Begna, Kebede
    Publication type:
    Article
    34
    35

    Current treatment preferences in chronic myeloid leukemia: The Mayo Clinic Physicians' survey.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 11, p. E626, doi. 10.1002/ajh.24866
    By:
    • Begna, Kebede;
    • Al-Kali, Aref;
    • Elliott, Michelle;
    • Foran, James;
    • Gangat, Naseema;
    • Hogan, William;
    • Hook, Christopher;
    • Leis, Jose;
    • Litzow, Mark;
    • Mesa, Ruben;
    • Palmer, Jeanne;
    • Pardanani, Animesh;
    • Patnaik, Mrinal;
    • Rivera, Candido;
    • Sproat, Lisa;
    • Tibes, Raoul;
    • Wolanskyj-Spinner, Alexandra;
    • Tefferi, Ayalew
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42

    A Phase II study of <sup>153</sup>Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.

    Published in:
    American Journal of Hematology, 2010, v. 85, n. 6, p. 409, doi. 10.1002/ajh.21696
    By:
    • Dispenzieri, Angela;
    • Wiseman, Gregory A.;
    • Lacy, Martha Q.;
    • Hayman, Suzanne R.;
    • Kumar, Shaji K.;
    • Buadi, Francis;
    • Dingli, David;
    • Laumann, Krista M.;
    • Allred, Jake;
    • Geyer, Susan M.;
    • Litzow, Mark R.;
    • Gastineau, Dennis A.;
    • Inwards, David J.;
    • Micallef, Ivana N.;
    • Ansell, Stephen M.;
    • Porrata, Luis;
    • Elliott, Michelle A.;
    • Johnston, Patrick B.;
    • Hogan, William J.;
    • Gertz, Morie A.
    Publication type:
    Article
    43
    44
    45

    Cutaneous Phototoxicity.

    Published in:
    Toxicologic Pathology, 2016, v. 44, n. 4, p. 545, doi. 10.1177/0192623316643617
    By:
    • Learn, Douglas B.;
    • Elliott, Michelle W.
    Publication type:
    Article
    46
    47
    48
    49

    Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome.

    Published in:
    European Journal of Haematology, 2008, v. 80, n. 5, p. 397, doi. 10.1111/j.1600-0609.2008.01037.x
    By:
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Hayman, Suzanne R.;
    • Kumar, Shaji K.;
    • Buadi, Francis;
    • Dingli, David;
    • Litzow, Mark R.;
    • Gastineau, Dennis A.;
    • Inwards, David J.;
    • Elliott, Michelle A.;
    • Micallef, Ivana N.;
    • Ansell, Stephen M.;
    • Hogan, William J.;
    • Porrata, Luis F.;
    • Johnston, Patrick A.;
    • Afessa, Bekele;
    • Bryce, Alan;
    • Kyle, Robert A.;
    • Gertz, Morie A.
    Publication type:
    Article
    50